From: The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013
ICD_WHO | 1986 | 1989 | 1992 | 1995 | 1998 | 2001 | 2004 | 2007 | 2010 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|
C00–14 lip, oral cavity and pharynx | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
C15 oesophagus | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
C16 stomach | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
C18–21 colon, rectum and anus | 0 | 0 | 0 | 0 | 1 | 2 | 4 | 5 | 5 | 6 |
C25 pancreas | 0 | 0 | 0 | 1 | 3 | 3 | 3 | 6 | 6 | 6 |
C33–34 lung (incl. trachea and bronchus) | 0 | 0 | 1 | 3 | 5 | 5 | 6 | 9 | 10 | 11 |
C43 melanoma of skin | 0 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 5 |
C45 mesothelioma | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
C50 breast | 0 | 1 | 2 | 4 | 7 | 11 | 12 | 13 | 16 | 16 |
C53 cervix uteri | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
C56 ovary | 0 | 0 | 1 | 2 | 3 | 3 | 3 | 4 | 5 | 5 |
C61 prostate | 0 | 3 | 4 | 5 | 6 | 6 | 6 | 6 | 7 | 8 |
C64 kidney | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 4 | 4 | 6 |
C70–72 brain, central nervous system | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 3 | 3 |
C73 thyroid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
C81 hodgkin lymphoma | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
C82–85, C96 non-hodgkin lymphoma | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 5 | 5 |
C88 + C90 multiple myeloma | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 4 | 4 |
C91–95 leukemia | 0 | 2 | 3 | 3 | 3 | 5 | 5 | 7 | 8 | 8 |
Mean | 0.0 | 0.4 | 0.7 | 1.2 | 1.8 | 2.5 | 2.8 | 3.8 | 4.5 | 4.8 |